Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
BMJ Open
; 9(5): e022031, 2019 05 28.
Article
in En
| MEDLINE
| ID: mdl-31142516
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinal Diseases
/
Recombinant Fusion Proteins
/
Receptors, Vascular Endothelial Growth Factor
/
Vascular Endothelial Growth Factor A
/
Bevacizumab
/
Ranibizumab
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
BMJ Open
Year:
2019
Type:
Article
Affiliation country:
Canada